Human Immunodeficiency Virus-Associated Malignancies: A Therapeutic Update

Author(s): Antonello Malfitano, Giuseppe Barbaro, Alessandro Perretti, Giorgio Barbarini.

Journal Name: Current HIV Research

Volume 10 , Issue 2 , 2012

Become EABM
Become Reviewer

Abstract:

Implementation of highly active antiretroviral therapy (HAART) has deeply changed the landscape of HIVassociated malignancies. Some AIDS-defining tumors, namely Primitive Lymphoma of Central Nervous System, have drastically declined, whereas a steady increase has been observed for non-AIDS-defining tumors, maybe due to longer survival of HIV-infected people. Easier immune restoration, subsequent to availability of a number of drugs targeting HIV at different points, has decreased opportunistic infections which hampered treatment of HIV-associated cancers. As a matter of fact these patients have been assimilated more and more with their negative counterpart, undergoing the same aggressive approach. Consistently, procedures that have been so far precluded to HIV+ subjects, such as transplant of hemopoietic stem cells, either autologous or allogenic, and liver transplant are expected to be performed more and more extensively in this population. Which also would mean a full removal of the stigma which has weighed on it.

Hence, it is true-like that malignancies and related problems may in the next future make up a main concern for the HIV specialist. Old and new challenges might be the drug-drug interaction of antiretrovirals or biotherapy-related infections or the debated question of an earlier HAART implementation in the course of HIV disease, with CD4+ cells >500/μl. In fact, if assimilation of HIV patients with cancer and the general population is a remarkable achieved goal, uniqueness of HIV infection in terms of immune status still makes HIV-associated cancer a unique chapter in the setting of Oncology.

Keywords: Human immunodeficiency virus, malignancies, chemotherapy, highly active antiretroviral therapy, biotherapy, stem cell rescue

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 10
ISSUE: 2
Year: 2012
Page: [123 - 132]
Pages: 10
DOI: 10.2174/157016212799937227
Price: $58

Article Metrics

PDF: 7